Nonclinical safety evaluation of erenumab, a CGRP receptor inhibitor for the prevention of migraine.
暂无分享，去创建一个
R. Davies | T. Monticello | H. Vargas | G. Chellman | A. Maassenvandenbrink | J. Bussiere | Cen Xu | E. Rubio-Beltrán | Kyung Hoon Kim | G. Balasubramanian | Charles Dean